Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

By bringing innovative products to market, pharmaceutical companies help people live longer, higher-quality lives — and our attorneys and other professionals are dedicated to facilitating that progress. Our professionals include former in-house counsel and senior executives for some of the world’s largest pharmaceutical companies, as well as an interdisciplinary team of experienced attorneys and professionals who provide regulatory, transactional, litigation, intellectual property and government affairs services tailored to the pharmaceutical industry. We help clients tackle business and financing pressures, regulatory scrutiny and litigation threats on a national and international scale. We have steered global pharma companies through multibillion-dollar transactions and helped international drug manufacturers accelerate drug development through creative joint ventures. Our IP attorneys work to patent your inventions in countries around the globe; shield your brands through trademark policing and anti-counterfeiting strategies; and negotiate commercial, licensing and other strategic agreements — freeing you to focus on product development and innovation. We serve as outside general counsel for regulatory compliance matters and support on all interactions with the Food and Drug Administration and other regulatory parties, including inspections, investigations and enforcement. And when disputes occur, our trial lawyers are there to handle any issue. Whether enforcing your rights or defending against alleged wrongdoing, including in product liability litigation, our team of skilled trial attorneys is ready to represent you in high-stakes, bet-the-company litigation every day.

Insights & Events

Latest

Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read  
Press Release May 2025

Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD

2 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Press Release May 2025

Faegre Drinker Grows Customs & International Trade Practice in Washington, D.C., Welcoming Prominent Trade Enforcement Partner Daniel Wilson

3 min read  
Updates May 2025

FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data

Reminder of Importance of Adequately Vetting Contract Research Organizations
5 min read  
May 2025

The Hidden Dangers of Alternative Funding Programs

1 min read  
Updates April 2025

Data Security Program, Medicare Advantage, Colorado Insurance Requirements & More

Artificial Intelligence Briefing
8 min read  
Speaking Engagement Recap November 20, 2024

Managed Care, Enforcement and Compliance

Healthcare Enforcement Compliance Conference
1 min read  
Speaking Engagement Recap November 18, 2024

Federal and State Enforcement of Private Equity Investment in Health Care

Healthcare Enforcement Compliance Conference
1 min read  
Insights
Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Updates May 2025

FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data

Reminder of Importance of Adequately Vetting Contract Research Organizations
5 min read  
May 2025

The Hidden Dangers of Alternative Funding Programs

1 min read  
Updates April 2025

Data Security Program, Medicare Advantage, Colorado Insurance Requirements & More

Artificial Intelligence Briefing
8 min read  
Updates April 2025

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

Biopharma & Medical Devices Briefing
5 min read  
Updates April 2025

Tariff Tactics and National Security: Decoding Section 232’s Role in Shaping Trade Policies

Comment Opportunities Available to Advocate for Exclusions and Limited Applications
6 min read  
Published Articles April 2025

Product Liability and Mass Torts Attorneys Contribute to International Comparative Legal Guides’ ‘Drug and Medical Device Litigation 2025’ Guide

1 min read  
Published Articles April 2025

Accuracy of Medicare Information Provided by State Health Insurance Assistance Programs

1 min read